Galera Therapeutics, Inc. (GRTX)
OTCMKTS
· Delayed Price · Currency is USD
0.0880
0.00 (0.00%)
Jun 29, 2026, 9:59 AM EST
Galera Therapeutics Employees
Galera Therapeutics had 3 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
$21,172,667
Market Cap
14.13M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Zeo ScientifiX | 20 |
| Inhibitor Therapeutics | 8 |
| Anebulo Pharmaceuticals | 3 |
| ZIVO Bioscience | 7 |
| Adaptimmune Therapeutics | 272 |
| Brainstorm Cell Therapeutics | 19 |
Galera Therapeutics News
- 2 months ago - Galera Therapeutics and Obsidian Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement - GlobeNewsWire
- 2 months ago - Galera Therapeutics, Obsidian Therapeutics enter merger agreement - TheFly
- 2 months ago - Obsidian Therapeutics and Galera Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement - Business Wire
- 8 months ago - Biossil to acquire Galera’s dismutase mimetics portfolio for up to $105M - TheFly
- 8 months ago - Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million - GlobeNewsWire
- 1 year ago - Galera Therapeutics completes acquisition of Nova Pharmaceuticals - TheFly
- 1 year ago - Galera Therapeutics completes acquisition of Nova Pharmaceuticals - GlobeNewsWire
- 2 years ago - Galera Therapeutics reports Q2 EPS (7c) vs. (48c) last year - TheFly